At present, it has been revealed that FSTL3 has an enhanced expression in A498, 786-O, Caki-1, and ACHN RCC cells by contrast to that in OCT2 cells (a normal human proximal renal tubular epithelial cell line). Here, FSTL3 is linked to renal cell carcinoma.